Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCRL | Q16602 | 6/20 | 0.56 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.52 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.52 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.52 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.50 |
| ▸ | REN | P00797 | 5/20 | 0.49 |
| ▸ | CALCR | P30988 | 4/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30358167 | 0.88 | CALCR (0.59) | CALCRLMAPK8MAPK9MAPK10CALCR | |
| SCHEMBL29634967 | 0.87 | MAPK8 (0.49) | CALCRLMAPK8MAPK9MAPK10RAMP1 | |
| SCHEMBL30607278 | 0.87 | CALCR (0.62) | CALCRLMAPK8MAPK9MAPK10CALCR | |
| SCHEMBL30804664 | 0.87 | CALCR (0.55) | CALCRLMAPK8MAPK9MAPK10REN | |
| SCHEMBL30974474 | 0.84 | CALCRL (0.59) | CALCRLRAMP1RENCALCRF2 | |
| SCHEMBL30862307 | 0.83 | CALCRL (0.54) | CALCRLMAPK8MAPK9MAPK10REN | |
| SCHEMBL29400662 | 0.83 | CALCRL (0.58) | CALCRLRAMP1CALCRF2 | |
| SCHEMBL30051241 | 0.83 | REN (0.55) | CALCRLMAPK8MAPK9MAPK10REN | |
| SCHEMBL30311249 | 0.82 | KDM1A (0.59) | CALCRLMAPK8MAPK9MAPK10REN | |
| SCHEMBL10655689 | 0.82 | REN (0.61) | RENF2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116490215-A | Targeted mediated endocytic drug delivery | CRM医疗有限公司 | 2023-07-25 | — | — | CN | disclosed |